The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients.
about
[Management of chronic hemodialysis patients with anemia: case study conducted in the Department of Nephrology and Hemodialysis at the University Hospital Point G in Mali].Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study.
P2860
The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The cost-utility of treating a ...... chronic hemodialysis patients.
@ast
The cost-utility of treating a ...... chronic hemodialysis patients.
@en
type
label
The cost-utility of treating a ...... chronic hemodialysis patients.
@ast
The cost-utility of treating a ...... chronic hemodialysis patients.
@en
prefLabel
The cost-utility of treating a ...... chronic hemodialysis patients.
@ast
The cost-utility of treating a ...... chronic hemodialysis patients.
@en
P2860
P356
P1476
The cost-utility of treating a ...... chronic hemodialysis patients
@en
P2093
Omar Maoujoud
P2860
P356
10.2147/IJNRD.S96027
P407
P577
2016-02-24T00:00:00Z